Trinity Biotech (TRIB) Gross Profit (2016 - 2024)
Historic Gross Profit for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to $4.9 million.
- Trinity Biotech's Gross Profit rose 678.78% to $4.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $21.4 million, marking a year-over-year increase of 1023.65%. This contributed to the annual value of $21.4 million for FY2024, which is 1023.65% up from last year.
- Trinity Biotech's Gross Profit amounted to $4.9 million in Q4 2024, which was up 678.78% from $5.3 million recorded in Q3 2024.
- In the past 5 years, Trinity Biotech's Gross Profit ranged from a high of $16.8 million in Q3 2020 and a low of $329000.0 during Q3 2022
- For the 5-year period, Trinity Biotech's Gross Profit averaged around $7.2 million, with its median value being $5.7 million (2022).
- Its Gross Profit has fluctuated over the past 5 years, first plummeted by 9630.34% in 2022, then soared by 120091.19% in 2023.
- Quarter analysis of 5 years shows Trinity Biotech's Gross Profit stood at $15.7 million in 2020, then plummeted by 53.77% to $7.2 million in 2021, then fell by 25.75% to $5.4 million in 2022, then fell by 15.03% to $4.6 million in 2023, then increased by 6.79% to $4.9 million in 2024.
- Its Gross Profit was $4.9 million in Q4 2024, compared to $5.3 million in Q3 2024 and $5.7 million in Q2 2024.